ID   AMD_HUMAN               Reviewed;         973 AA.
AC   P19021; A6NMR0; A8K293; O43211; O95080; Q16252; Q16253; Q54A45;
AC   Q86U53; Q8WVC7; Q9UCG0;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   10-MAY-2017, entry version 194.
DE   RecName: Full=Peptidyl-glycine alpha-amidating monooxygenase;
DE            Short=PAM;
DE   Includes:
DE     RecName: Full=Peptidylglycine alpha-hydroxylating monooxygenase;
DE              Short=PHM;
DE              EC=1.14.17.3;
DE   Includes:
DE     RecName: Full=Peptidyl-alpha-hydroxyglycine alpha-amidating lyase;
DE              EC=4.3.2.5;
DE     AltName: Full=Peptidylamidoglycolate lyase;
DE              Short=PAL;
DE   Flags: Precursor;
GN   Name=PAM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Thyroid carcinoma;
RX   PubMed=2357221; DOI=10.1016/0006-291X(90)90366-U;
RA   Glauder J., Ragg H., Rauch J., Engels J.W.;
RT   "Human peptidylglycine alpha-amidating monooxygenase: cDNA, cloning
RT   and functional expression of a truncated form in COS cells.";
RL   Biochem. Biophys. Res. Commun. 169:551-558(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RX   PubMed=7999037; DOI=10.1006/bbrc.1994.2662;
RA   Tateishi K., Arakawa F., Misumi Y., Treston A.M., Vos M., Matsuoka Y.;
RT   "Isolation and functional expression of human pancreatic
RT   peptidylglycine alpha-amidating monooxygenase.";
RL   Biochem. Biophys. Res. Commun. 205:282-290(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), COFACTOR, AND ENZYME
RP   REGULATION.
RC   TISSUE=Heart;
RX   PubMed=12699694; DOI=10.1016/S1046-5928(02)00684-8;
RA   Satani M., Takahashi K., Sakamoto H., Harada S., Kaida Y., Noguchi M.;
RT   "Expression and characterization of human bifunctional peptidylglycine
RT   alpha-amidating monooxygenase.";
RL   Protein Expr. Purif. 28:293-302(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-973 (ISOFORM 4).
RC   TISSUE=Kidney;
RA   Chung B.H., Oh G.H., Choi E.S.;
RT   "The alpha-amidating monooxygenase gene of human kidney.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 707-973 (ISOFORM 6).
RC   TISSUE=Brain;
RX   PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [11]
RP   SULFATION AT TYR-875 (ISOFORM 4), AND SULFATION AT TYR-893 (ISOFORM
RP   3).
RX   PubMed=8144680;
RA   Yun H.Y., Keutmann H.T., Eipper B.A.;
RT   "Alternative splicing governs sulfation of tyrosine or oligosaccharide
RT   on peptidylglycine alpha-amidating monooxygenase.";
RL   J. Biol. Chem. 269:10946-10955(1994).
RN   [12]
RP   PHOSPHORYLATION AT THR-943 AND SER-946 BY UHMK1.
RX   PubMed=10574929; DOI=10.1074/jbc.274.49.34646;
RA   Caldwell B.D., Darlington D.N., Penzes P., Johnson R.C., Eipper B.A.,
RA   Mains R.E.;
RT   "The novel kinase peptidylglycine alpha-amidating monooxygenase
RT   cytosolic interactor protein 2 interacts with the cytosolic routing
RT   determinants of the peptide processing enzyme peptidylglycine alpha-
RT   amidating monooxygenase.";
RL   J. Biol. Chem. 274:34646-34656(1999).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-946, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-929, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942 AND SER-946, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-918 AND SER-929, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes 2 sequential steps in
CC       C-terminal alpha-amidation of peptides. The monooxygenase part
CC       produces an unstable peptidyl(2-hydroxyglycine) intermediate that
CC       is dismutated to glyoxylate and the corresponding desglycine
CC       peptide amide by the lyase part. C-terminal amidation of peptides
CC       such as neuropeptides is essential for full biological activity.
CC   -!- CATALYTIC ACTIVITY: Peptidylglycine + ascorbate + O(2) =
CC       peptidyl(2-hydroxyglycine) + dehydroascorbate + H(2)O.
CC   -!- CATALYTIC ACTIVITY: Peptidylamidoglycolate = peptidyl amide +
CC       glyoxylate.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:12699694};
CC       Note=Zn(2+) is required for the lyase reaction.
CC       {ECO:0000269|PubMed:12699694};
CC   -!- COFACTOR:
CC       Name=Cu(2+); Xref=ChEBI:CHEBI:29036;
CC         Evidence={ECO:0000269|PubMed:12699694};
CC       Note=Binds 2 copper ions per subunit for the monooxygenase
CC       reaction. {ECO:0000269|PubMed:12699694};
CC   -!- ENZYME REGULATION: Inhibited by EDTA, phenylglyoxal and diethyl
CC       pyrocarbonate. {ECO:0000269|PubMed:12699694}.
CC   -!- SUBUNIT: Monomer. Interacts with RASSF9 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Secreted. Note=Secreted from
CC       secretory granules.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Secreted. Note=Secreted from
CC       secretory granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P19021-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P19021-2; Sequence=VSP_001227;
CC       Name=3;
CC         IsoId=P19021-3; Sequence=VSP_001228;
CC         Note=Soluble. Contains a sulfotyrosine at position 893.
CC         {ECO:0000269|PubMed:8144680};
CC       Name=4;
CC         IsoId=P19021-4; Sequence=VSP_001229;
CC         Note=Soluble. Contains a sulfotyrosine at position 875.
CC         {ECO:0000269|PubMed:8144680};
CC       Name=5;
CC         IsoId=P19021-5; Sequence=VSP_038691;
CC       Name=6;
CC         IsoId=P19021-6; Sequence=VSP_042209;
CC   -!- SIMILARITY: In the C-terminal section; belongs to the peptidyl-
CC       alpha-hydroxyglycine alpha-amidating lyase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the copper type
CC       II ascorbate-dependent monooxygenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD01439.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37721; AAA36414.1; -; mRNA.
DR   EMBL; S75037; AAB32775.1; -; mRNA.
DR   EMBL; S75038; AAB32776.1; -; mRNA.
DR   EMBL; AB095007; BAC22594.1; -; mRNA.
DR   EMBL; AK290158; BAF82847.1; -; mRNA.
DR   EMBL; BT007419; AAP36087.1; -; mRNA.
DR   EMBL; AC008779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471086; EAW49085.1; -; Genomic_DNA.
DR   EMBL; BC018127; AAH18127.1; -; mRNA.
DR   EMBL; AF010472; AAD01439.1; ALT_INIT; mRNA.
DR   EMBL; AF035320; AAB88190.1; -; mRNA.
DR   CCDS; CCDS4092.1; -. [P19021-3]
DR   CCDS; CCDS4093.1; -. [P19021-2]
DR   CCDS; CCDS4094.1; -. [P19021-4]
DR   CCDS; CCDS43348.1; -. [P19021-5]
DR   CCDS; CCDS54885.1; -. [P19021-1]
DR   PIR; A35477; URHUAP.
DR   RefSeq; NP_000910.2; NM_000919.3. [P19021-5]
DR   RefSeq; NP_001170777.1; NM_001177306.1. [P19021-1]
DR   RefSeq; NP_001306872.1; NM_001319943.1.
DR   RefSeq; NP_620121.1; NM_138766.2. [P19021-3]
DR   RefSeq; NP_620176.1; NM_138821.2. [P19021-2]
DR   RefSeq; NP_620177.1; NM_138822.2. [P19021-4]
DR   RefSeq; XP_016864986.1; XM_017009497.1. [P19021-5]
DR   RefSeq; XP_016864990.1; XM_017009501.1. [P19021-6]
DR   RefSeq; XP_016864994.1; XM_017009505.1. [P19021-3]
DR   UniGene; Hs.369430; -.
DR   ProteinModelPortal; P19021; -.
DR   SMR; P19021; -.
DR   BioGrid; 111101; 18.
DR   IntAct; P19021; 2.
DR   STRING; 9606.ENSP00000306100; -.
DR   BindingDB; P19021; -.
DR   ChEMBL; CHEMBL2544; -.
DR   DrugBank; DB04150; Threonine Derivative.
DR   DrugBank; DB00126; Vitamin C.
DR   iPTMnet; P19021; -.
DR   PhosphoSitePlus; P19021; -.
DR   BioMuta; PAM; -.
DR   DMDM; 23503036; -.
DR   EPD; P19021; -.
DR   MaxQB; P19021; -.
DR   PaxDb; P19021; -.
DR   PeptideAtlas; P19021; -.
DR   PRIDE; P19021; -.
DR   DNASU; 5066; -.
DR   Ensembl; ENST00000304400; ENSP00000306100; ENSG00000145730. [P19021-5]
DR   Ensembl; ENST00000346918; ENSP00000282992; ENSG00000145730. [P19021-4]
DR   Ensembl; ENST00000348126; ENSP00000314638; ENSG00000145730. [P19021-2]
DR   Ensembl; ENST00000438793; ENSP00000396493; ENSG00000145730. [P19021-1]
DR   Ensembl; ENST00000455264; ENSP00000403461; ENSG00000145730. [P19021-3]
DR   GeneID; 5066; -.
DR   KEGG; hsa:5066; -.
DR   UCSC; uc003kns.4; human. [P19021-1]
DR   CTD; 5066; -.
DR   DisGeNET; 5066; -.
DR   GeneCards; PAM; -.
DR   HGNC; HGNC:8596; PAM.
DR   HPA; CAB026119; -.
DR   HPA; HPA042260; -.
DR   MIM; 170270; gene.
DR   neXtProt; NX_P19021; -.
DR   OpenTargets; ENSG00000145730; -.
DR   PharmGKB; PA32926; -.
DR   eggNOG; KOG3567; Eukaryota.
DR   eggNOG; ENOG410XS0X; LUCA.
DR   GeneTree; ENSGT00730000111058; -.
DR   HOVERGEN; HBG004218; -.
DR   InParanoid; P19021; -.
DR   KO; K00504; -.
DR   KO; K18200; -.
DR   OMA; MDTVHHM; -.
DR   OrthoDB; EOG091G067T; -.
DR   PhylomeDB; P19021; -.
DR   TreeFam; TF320698; -.
DR   BRENDA; 1.14.17.3; 2681.
DR   BRENDA; 4.3.2.5; 2681.
DR   SignaLink; P19021; -.
DR   SIGNOR; P19021; -.
DR   ChiTaRS; PAM; human.
DR   GeneWiki; Peptidylglycine_alpha-amidating_monooxygenase; -.
DR   GenomeRNAi; 5066; -.
DR   PRO; PR:P19021; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000145730; -.
DR   CleanEx; HS_PAM; -.
DR   ExpressionAtlas; P19021; baseline and differential.
DR   Genevisible; P19021; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0030667; C:secretory granule membrane; IEA:Ensembl.
DR   GO; GO:0005802; C:trans-Golgi network; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0005507; F:copper ion binding; IEA:Ensembl.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0004598; F:peptidylamidoglycolate lyase activity; IDA:UniProtKB.
DR   GO; GO:0004504; F:peptidylglycine monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007595; P:lactation; IEA:Ensembl.
DR   GO; GO:0060173; P:limb development; IEA:Ensembl.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:0022602; P:ovulation cycle process; IEA:Ensembl.
DR   GO; GO:0001519; P:peptide amidation; IDA:UniProtKB.
DR   GO; GO:0018032; P:protein amidation; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0050708; P:regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0009268; P:response to pH; IEA:Ensembl.
DR   GO; GO:0009404; P:toxin metabolic process; IEA:Ensembl.
DR   Gene3D; 2.120.10.30; -; 1.
DR   Gene3D; 2.60.120.230; -; 1.
DR   Gene3D; 2.60.120.310; -; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR014784; Cu2_ascorb_mOase-like_C.
DR   InterPro; IPR020611; Cu2_ascorb_mOase_CS-1.
DR   InterPro; IPR014783; Cu2_ascorb_mOase_CS-2.
DR   InterPro; IPR000323; Cu2_ascorb_mOase_N.
DR   InterPro; IPR024548; Cu2_monoox_C.
DR   InterPro; IPR001258; NHL_repeat.
DR   InterPro; IPR013017; NHL_repeat_subgr.
DR   InterPro; IPR000720; PHM/PAL.
DR   InterPro; IPR008977; PHM/PNGase_F_dom.
DR   Pfam; PF03712; Cu2_monoox_C; 1.
DR   Pfam; PF01082; Cu2_monooxygen; 1.
DR   Pfam; PF01436; NHL; 3.
DR   PRINTS; PR00790; PAMONOXGNASE.
DR   SUPFAM; SSF49742; SSF49742; 2.
DR   PROSITE; PS00084; CU2_MONOOXYGENASE_1; 1.
DR   PROSITE; PS00085; CU2_MONOOXYGENASE_2; 1.
DR   PROSITE; PS51125; NHL; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cleavage on pair of basic residues;
KW   Complete proteome; Copper; Disulfide bond; Glycoprotein; Lyase;
KW   Membrane; Metal-binding; Monooxygenase; Multifunctional enzyme;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal; Sulfation; Transmembrane;
KW   Transmembrane helix; Vitamin C; Zinc.
FT   SIGNAL        1     20       {ECO:0000305}.
FT   PROPEP       21     30       {ECO:0000305}.
FT                                /FTId=PRO_0000006361.
FT   CHAIN        31    973       Peptidyl-glycine alpha-amidating
FT                                monooxygenase.
FT                                /FTId=PRO_0000006362.
FT   TOPO_DOM     31    863       Intragranular. {ECO:0000255}.
FT   TRANSMEM    864    887       Helical. {ECO:0000255}.
FT   TOPO_DOM    888    973       Cytoplasmic. {ECO:0000255}.
FT   REPEAT      498    541       NHL 1.
FT   REPEAT      567    608       NHL 2.
FT   REPEAT      617    662       NHL 3.
FT   REPEAT      670    714       NHL 4.
FT   REPEAT      766    809       NHL 5.
FT   REGION        1    494       Peptidylglycine alpha-hydroxylating
FT                                monooxygenase. {ECO:0000250}.
FT   REGION      495    817       Peptidyl-alpha-hydroxyglycine alpha-
FT                                amidating lyase. {ECO:0000250}.
FT   REGION      925    942       Interaction with RASSF9. {ECO:0000250}.
FT   METAL       102    102       Copper A. {ECO:0000250}.
FT   METAL       103    103       Copper A. {ECO:0000250}.
FT   METAL       167    167       Copper A. {ECO:0000250}.
FT   METAL       237    237       Copper B. {ECO:0000250}.
FT   METAL       239    239       Copper B. {ECO:0000250}.
FT   METAL       309    309       Copper B. {ECO:0000250}.
FT   MOD_RES     918    918       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     929    929       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     942    942       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     943    943       Phosphothreonine.
FT                                {ECO:0000269|PubMed:10574929}.
FT   MOD_RES     946    946       Phosphoserine; by UHMK1; in vitro.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:10574929}.
FT   MOD_RES     957    957       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14925}.
FT   CARBOHYD    762    762       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     42    181       {ECO:0000250}.
FT   DISULFID     76    121       {ECO:0000250}.
FT   DISULFID    109    126       {ECO:0000250}.
FT   DISULFID    222    329       {ECO:0000250}.
FT   DISULFID    288    310       {ECO:0000250}.
FT   DISULFID    631    652       {ECO:0000250}.
FT   DISULFID    699    710       {ECO:0000250}.
FT   VAR_SEQ     388    494       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_001227.
FT   VAR_SEQ     829    914       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.9}.
FT                                /FTId=VSP_001229.
FT   VAR_SEQ     829    896       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:7999037}.
FT                                /FTId=VSP_001228.
FT   VAR_SEQ     896    896       G -> GA (in isoform 5).
FT                                {ECO:0000303|PubMed:2357221}.
FT                                /FTId=VSP_038691.
FT   VAR_SEQ     897    914       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:9110174}.
FT                                /FTId=VSP_042209.
FT   VARIANT      49     49       V -> L (in dbSNP:rs2230458).
FT                                /FTId=VAR_055694.
FT   CONFLICT     26     26       S -> P (in Ref. 4; BAF82847).
FT                                {ECO:0000305}.
FT   CONFLICT    574    574       G -> E (in Ref. 1; AAA36414).
FT                                {ECO:0000305}.
FT   CONFLICT    774    774       P -> L (in Ref. 4; BAF82847).
FT                                {ECO:0000305}.
FT   CONFLICT    830    831       Missing (in Ref. 2; AAB32775).
FT                                {ECO:0000305}.
SQ   SEQUENCE   973 AA;  108332 MW;  8A089B657F56EE39 CRC64;
     MAGRVPSLLV LLVFPSSCLA FRSPLSVFKR FKETTRPFSN ECLGTTRPVV PIDSSDFALD
     IRMPGVTPKQ SDTYFCMSMR IPVDEEAFVI DFKPRASMDT VHHMLLFGCN MPSSTGSYWF
     CDEGTCTDKA NILYAWARNA PPTRLPKGVG FRVGGETGSK YFVLQVHYGD ISAFRDNNKD
     CSGVSLHLTR LPQPLIAGMY LMMSVDTVIP AGEKVVNSDI SCHYKNYPMH VFAYRVHTHH
     LGKVVSGYRV RNGQWTLIGR QSPQLPQAFY PVGHPVDVSF GDLLAARCVF TGEGRTEATH
     IGGTSSDEMC NLYIMYYMEA KHAVSFMTCT QNVAPDMFRT IPPEANIPIP VKSDMVMMHE
     HHKETEYKDK IPLLQQPKRE EEEVLDQGDF YSLLSKLLGE REDVVHVHKY NPTEKAESES
     DLVAEIANVV QKKDLGRSDA REGAEHERGN AILVRDRIHK FHRLVSTLRP PESRVFSLQQ
     PPPGEGTWEP EHTGDFHMEE ALDWPGVYLL PGQVSGVALD PKNNLVIFHR GDHVWDGNSF
     DSKFVYQQIG LGPIEEDTIL VIDPNNAAVL QSSGKNLFYL PHGLSIDKDG NYWVTDVALH
     QVFKLDPNNK EGPVLILGRS MQPGSDQNHF CQPTDVAVDP GTGAIYVSDG YCNSRIVQFS
     PSGKFITQWG EESSGSSPLP GQFTVPHSLA LVPLLGQLCV ADRENGRIQC FKTDTKEFVR
     EIKHSSFGRN VFAISYIPGL LFAVNGKPHF GDQEPVQGFV MNFSNGEIID IFKPVRKHFD
     MPHDIVASED GTVYIGDAHT NTVWKFTLTE KLEHRSVKKA GIEVQEIKEA EAVVETKMEN
     KPTSSELQKM QEKQKLIKEP GSGVPVVLIT TLLVIPVVVL LAIAIFIRWK KSRAFGDSEH
     KLETSSGRVL GRFRGKGSGG LNLGNFFASR KGYSRKGFDR LSTEGSDQEK EDDGSESEEE
     YSAPLPALAP SSS
//
